CytomX Therapeutics
CTMX
CTMX
119 hedge funds and large institutions have $299M invested in CytomX Therapeutics in 2019 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 44 increasing their positions, 35 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
119
Holders Change
+6
Holders Change %
+5.31%
% of All Funds
2.35%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
23
Increased
44
Reduced
35
Closed
17
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
First Manhattan
New York
|
$8.13M |
2 |
Point72 Asset Management
Stamford,
Connecticut
|
$5.99M |
3 |
Renaissance Technologies
New York
|
$17.1M |
4 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
$4.01M |
5 |
EC
EcoR1 Capital
San Francisco,
California
|
$3.41M |